(Q44596775)

4 December 2017

title

Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma (English)

1 reference

4 December 2017

1 reference

5

1 reference

4 December 2017

Martín A

1

1 reference

4 December 2017

Pérez-Simón JA

2

1 reference

4 December 2017

Caballero MD

3

1 reference

4 December 2017

López N

4

1 reference

4 December 2017

Vázquez L

6

1 reference

4 December 2017

del Cañizo MC

7

1 reference

4 December 2017

San Miguel JF

8

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Bone Marrow Transplantation

4 December 2017

published in

1 reference

4 December 2017

volume

33

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

579-587

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704401

4 December 2017

exact match

0 references

cites work

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Cell Proliferation and the Action of Cytotoxic Agents on Haemopoietic Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Screening of cytotoxic drugs for residual bone marrow damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Residual marrow injury following cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Treatment of therapy-related leukemia and myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704401

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704401

1 reference

4 December 2017

1 reference